Berberine is een stof die regelrecht uit de traditionele Chinese geneeskunde (TCM) komt, maar die ook in planten met medische toepassingen voorkomt in de rest van de wereld. Volgens moderne maatstaven helpt berberine de bloedsuiker van diabetici onder controle te houden en behandelt het andere aspecten van het metabool syndroom. Rond darmproblemen, waar het aanvankelijk tegen gebruikt werd, bestaan opvallend minder klinische studies en moeten we eerder beroep doen op informatie afkomstig uit de traditionele geneeskunde.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
1. Imenshahidi M, Hosseinzadeh H. Berberis vulgaris and berberine: an update review. Phytother Res. 2016 Aug 16. doi: 10.1002/ptr.5693
2. Caliceti C, Franco P et al. Berberine: New insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Curr Med Chem. 2016;23(14):1460-76
3. Vuddanda PR, Chakraborty S, Singh S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs. 2010 Oct;19(10):1297-307
4. Pang B, Zhao LH, Zhou Q et al. Application of berberine on treating type 2 diabetes mellitus. Int J Endocrinol. 2015;2015:905749
5. Lan J, Zhao Y et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015 Feb 23;161:69-81
10. Pérez-Rubio KG, González-Ortiz M et al. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. 2013 Oct;11(5):366-9
11. Yan HM, Xia MF, Wang Y et al. Efficacy of berberine in patients with non-alcoholic fatty liver disease. PLoS One. 2015 Aug 7;10(8):e0134172
12. Dong H, Zhao Y, Zhao L et al. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med. 2013 Apr;79(6):437-46
13. Pirro M, Mannarino MR et al. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016 Aug;110:76-88
14. Meng S, Wang LS et al. Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. Clin Exp Pharmacol Physiol. 2012 May;39(5):406-11
15. Zarei A, Changizi-Ashtiyani S et al. A quick overview on some aspects of endocrinological and therapeutic effects of Berberis vulgaris L. Avicenna J Phytomed. 2015 Nov-Dec;5(6):485-97
16. Cicero AF, Reggi A et al. Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia. High Blood Press Cardiovasc Prev. 2014 Sep;21(3):221-6
17. Wei W, Zhao H, Wang A et al. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012 Jan;166(1):99-105
18. Li L, Li C, Pan P et al. A single arm pilot study of effects of berberine on the menstrual pattern, ovulation rate, hormonal and metabolic profiles in anovulatory Chinese women with polycystic ovary syndrome. PLoS One. 2015 Dec 8;10(12):e0144072
19. Wu XK, Wang YY, Liu JP et al. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome. Fertil Steril. 2016 Sep 1;106(3):757-765.e1
20. An Y, Sun Z, Zhang Y et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014 Mar;80(3):425-31
21. Ahmed T, Gilani AU et al. Berberine and neurodegeneration: A review of literature. Pharmacol Rep. 2015 Oct;67(5):970-9
22. Chen C, Tao C, Liu Z et al. A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res. 2015 Nov;29(11):1822-7
23. Linn YC, Lu J, Lim LC et al. Berberine-induced haemolysis revisited: safety of Rhizoma coptidis and Cortex phellodendri in chronic haematological diseases. Phytother Res. 2012 May;26(5):682-6
24. Menees S, Saad R, Chey WD. Agents that act luminally to treat diarrhoea and constipation. Nat Rev Gastroenterol Hepatol. 2012 Nov;9(11):661-74
25. Zhang H, Wei J, Xue R et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010 Feb;59(2):285-92
26. Sheng ZX, Xie DH. Therapeutic effect of berberine on the levels of inflammatory factors in type 2 diabetic patients. New Medicine. 2010; 41(3):177-180
27. Li Z, Liu LH. Therapeutic efficacy of combined berberine and glipizide on type 2 diabetes mellitus. Yi Xue Lin Chuang Za Zhi. 2007; 24(1):61-64
28. Wu D, Wei J. Clinical observation on berberine treating type 2 diabetes mellitus. Acta Universitatis Medicinalis Nanjing. 2009; 29(5):736-738
29. Zeng XH, Zeng XJ, Li YY. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2003 Jul 15;92(2):173-6
30. An Y, Sun Z, Zhang Y et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014 Mar;80(3):425-31
31. Sheng WD, Jiddawi MS et al. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Afr Med J. 1997 May;74(5):283-4
32. Rabbani GH, Butler T, Knight J et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis. 1987 May;155(5):979-84
